<?xml version="1.0" encoding="UTF-8"?>
<ref id="B81">
 <label>81.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Du</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Sui</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection</article-title>. 
  <source>J Immunol.</source> (
  <year>2008</year>) 
  <volume>180</volume>:
  <fpage>948</fpage>â€“
  <lpage>56</lpage>. 
  <pub-id pub-id-type="doi">10.4049/jimmunol.180.2.948</pub-id>
  <?supplied-pmid 18178835?>
  <pub-id pub-id-type="pmid">18178835</pub-id>
 </mixed-citation>
</ref>
